Esperion Therapeutics, Inc. Annual Operating Margin in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Esperion Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2019 to 2023.
  • Esperion Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was 1.78 %.
  • Esperion Therapeutics, Inc. annual Operating Margin for 2023 was -134 %, a 43.8% increase from 2022.
  • Esperion Therapeutics, Inc. annual Operating Margin for 2022 was -238 %, a 17.7% increase from 2021.
  • Esperion Therapeutics, Inc. annual Operating Margin for 2021 was -289 %, a 442% decline from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -134 +104 +43.8% Jan 1, 2023 Dec 31, 2023
2022 -238 +51.2 +17.7% Jan 1, 2022 Dec 31, 2022
2021 -289 -236 -442% Jan 1, 2021 Dec 31, 2021
2020 -53.4 +9.4 +15% Jan 1, 2020 Dec 31, 2020
2019 -62.8 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.